<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>EBD Blog &#187; medication</title>
	<atom:link href="http://EBDBlog.com/tag/medication/feed/" rel="self" type="application/rss+xml" />
	<link>http://EBDBlog.com</link>
	<description>News, commentary, resources, and more about Emotional and Behavioral Disorders.</description>
	<lastBuildDate>Tue, 15 May 2012 19:59:36 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>FDA warns seller of chelation product</title>
		<link>http://EBDBlog.com/2010/06/fda-warns-seller-of-chelation-product/</link>
		<comments>http://EBDBlog.com/2010/06/fda-warns-seller-of-chelation-product/#comments</comments>
		<pubDate>Thu, 24 Jun 2010 21:46:46 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Autism]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[chelation]]></category>
		<category><![CDATA[effective treatment]]></category>
		<category><![CDATA[evidence-based practice]]></category>
		<category><![CDATA[Families]]></category>
		<category><![CDATA[intervention]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[Parents]]></category>
		<category><![CDATA[public health]]></category>
		<category><![CDATA[science]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=1168</guid>
		<description><![CDATA[The U.S. Food and Drug Administration (FDA) issued a warning letter to the producer of a product that is sometimes used by people hoping to eliminate heavy metals from children&#8217;s bodies (e.g., chelate mercury from children with autism). In a letter addressed to Boyd D. Haley of CTI Science Inc., Teresa C. Thompson of the [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2010/06/fda-warns-seller-of-chelation-product/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Fish oil and adolescent psychosis</title>
		<link>http://EBDBlog.com/2010/02/fish-oil-and-adolescent-psychosis/</link>
		<comments>http://EBDBlog.com/2010/02/fish-oil-and-adolescent-psychosis/#comments</comments>
		<pubDate>Tue, 02 Feb 2010 11:46:37 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Schizophrenia]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[evidence]]></category>
		<category><![CDATA[intervention]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[psychosis]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[science]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[youth]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=1106</guid>
		<description><![CDATA[During the 40 weeks after receiving a brief course of &#969;-3 (&#8220;omega three&#8221;) polyunsaturated fatty acids, adolescents at risk for psychotic disorders were less likely to progress to psychotic status than similar peers who did not receive the supplement. In the study by G. Paul Amminger and colleagues, the youths in the treated group also [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2010/02/fish-oil-and-adolescent-psychosis/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Jani&#8217;s story updated</title>
		<link>http://EBDBlog.com/2009/12/janis-story-updated/</link>
		<comments>http://EBDBlog.com/2009/12/janis-story-updated/#comments</comments>
		<pubDate>Tue, 29 Dec 2009 13:13:36 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Families]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Schizophrenia]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[mental illness]]></category>
		<category><![CDATA[Parents]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=1077</guid>
		<description><![CDATA[In &#8220;Hushing the intruders in her brain,&#8221; Shari Roan continued her account of childhood-onset schizophrenia as experieinced by January (&#8216;Jani&#8217;) Schofield. In the current story, Ms. Roan provided an update about Jani&#8217;s and her family&#8217;s life and progress. The coverage includes content about changes in Jani&#8217;s therapy and medications, the family&#8217;s living situation, and other [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2009/12/janis-story-updated/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Baseless, risky therapies for Autism</title>
		<link>http://EBDBlog.com/2009/11/baseless-risky-therapies-for-autism/</link>
		<comments>http://EBDBlog.com/2009/11/baseless-risky-therapies-for-autism/#comments</comments>
		<pubDate>Sat, 21 Nov 2009 21:20:07 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Autism]]></category>
		<category><![CDATA[Families]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[bologna]]></category>
		<category><![CDATA[chelation]]></category>
		<category><![CDATA[effective treatment]]></category>
		<category><![CDATA[evidence-based practice]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[therapy]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=997</guid>
		<description><![CDATA[Writing in the Chicago (IL, US) Tribune under the headline &#8220;Autism treatments: Risky alternative therapies have little basis in science&#8221; Trine Tsouderos and Patricia Callahan reported about the background and myriad problems with many treatments used as therapy for children with Autism. They expose the lack of evidentiary support for therapies ranging from mega-doses of [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2009/11/baseless-risky-therapies-for-autism/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Meds cause weight gains</title>
		<link>http://EBDBlog.com/2009/11/meds-cause-weight-gains/</link>
		<comments>http://EBDBlog.com/2009/11/meds-cause-weight-gains/#comments</comments>
		<pubDate>Sun, 01 Nov 2009 14:54:38 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Autism]]></category>
		<category><![CDATA[Families]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Schizophrenia]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[therapy]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=965</guid>
		<description><![CDATA[Children and youths who were treated with &#8220;atypical antipsychotic medications&#8221; (aripiprazole, olanzapine, quetiapine, or risperidone) gained substantial weight and had changes in their metabolism in a study reported by Christoph Correll and colleagues in the Journal of the American Medical Association. The drugs, which are used to treat childhood schizophrenia, bipolar disorder, and (sometimes) Autism, [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2009/11/meds-cause-weight-gains/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Secretin reminder</title>
		<link>http://EBDBlog.com/2009/08/secretin-reminder/</link>
		<comments>http://EBDBlog.com/2009/08/secretin-reminder/#comments</comments>
		<pubDate>Mon, 17 Aug 2009 10:46:39 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Autism]]></category>
		<category><![CDATA[Musings]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[effective treatment]]></category>
		<category><![CDATA[evidence-based practice]]></category>
		<category><![CDATA[intervention]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[science]]></category>
		<category><![CDATA[secretin]]></category>
		<category><![CDATA[therapy]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=908</guid>
		<description><![CDATA[Although I have followed the promotion of secretin as a treatment for Autism pretty much since the first reports about it, I hadn&#8217;t checked on it lately. My initial foray into the topic in 1998 resulted in some skepticism with hedges. As the research evolved, it became clear that the skepticism was warranted. However, I [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2009/08/secretin-reminder/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Screening teens</title>
		<link>http://EBDBlog.com/2009/08/screening-teens/</link>
		<comments>http://EBDBlog.com/2009/08/screening-teens/#comments</comments>
		<pubDate>Thu, 06 Aug 2009 10:05:15 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Acting in]]></category>
		<category><![CDATA[Assessment]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[Families]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[current issues]]></category>
		<category><![CDATA[effective treatment]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[Mental health]]></category>
		<category><![CDATA[mental illness]]></category>
		<category><![CDATA[Parents]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[youth]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=892</guid>
		<description><![CDATA[Writing under the headline &#8220;Pros and cons of screening teens for depression,&#8221; Brendan Borrell examined some of the issues that sometimes roar around surveying youths to identify those who are depressed or at risk for depression. Mr. Borrell&#8217;s article, which is one in a series of articles about depression appearing in the Los Angeles Times, [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2009/08/screening-teens/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Citalopram&#8217;s non-effects</title>
		<link>http://EBDBlog.com/2009/08/citaloprams-non-effects/</link>
		<comments>http://EBDBlog.com/2009/08/citaloprams-non-effects/#comments</comments>
		<pubDate>Mon, 03 Aug 2009 18:13:07 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Autism]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[effective treatment]]></category>
		<category><![CDATA[intervention]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[therapy]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=881</guid>
		<description><![CDATA[Citalopram, one of the class of drugs known as selective serotonin reuptake inhibitors (SSRIs) which are usually used to address depression, did not yield beneficial results in a recent study of whether the use of the drug with children and youth with Autism reduced repetitive behaviors. The study, reported by Bryan King and colleagues, included [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2009/08/citaloprams-non-effects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Danny Watt&#8217;s story</title>
		<link>http://EBDBlog.com/2009/07/danny-watts-story/</link>
		<comments>http://EBDBlog.com/2009/07/danny-watts-story/#comments</comments>
		<pubDate>Tue, 28 Jul 2009 10:50:28 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Bi-polar]]></category>
		<category><![CDATA[Families]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Schizophrenia]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Autism]]></category>
		<category><![CDATA[co-occurrence]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[dual diagnoses]]></category>
		<category><![CDATA[intervention]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[mental illness]]></category>
		<category><![CDATA[Parents]]></category>
		<category><![CDATA[substance abuse]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[youth]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=862</guid>
		<description><![CDATA[The parents of Daniel Watt, a youth who had multiple problems, told the story of their son&#8217;s life and suicide. Tom Jackman of the Washington Post reported the story of Danny and his parents, helping explain some of the problems of addressing the needs of children with multiple diagnoses&#8212;co-morbid schizoaffective disorder and substance abuse, in [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2009/07/danny-watts-story/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Sleep predictors of later depression</title>
		<link>http://EBDBlog.com/2009/06/sleep-predictors-of-later-depression/</link>
		<comments>http://EBDBlog.com/2009/06/sleep-predictors-of-later-depression/#comments</comments>
		<pubDate>Mon, 15 Jun 2009 14:39:58 +0000</pubDate>
		<dc:creator>JohnL</dc:creator>
				<category><![CDATA[Acting in]]></category>
		<category><![CDATA[Assessment]]></category>
		<category><![CDATA[Causes]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[Families]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[The press]]></category>
		<category><![CDATA[adults]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[neurology]]></category>
		<category><![CDATA[neuropsych]]></category>
		<category><![CDATA[Parents]]></category>
		<category><![CDATA[youth]]></category>

		<guid isPermaLink="false">http://EBDBlog.com/?p=774</guid>
		<description><![CDATA[Adolescents who are at risk for later episodes of major depressive disorders differ from their peers who are not at risk on multiple measures of rapid eye movement (REM) and hypothalamic-pituitary-adrenal (HPA) activity during sleep, according to a study by Uma Rao and colleagues that appeared this fall in Neuropsychopharmacology . Early depressive episodes that occur [...]]]></description>
		<wfw:commentRss>http://EBDBlog.com/2009/06/sleep-predictors-of-later-depression/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

